sanofi-aventis announces blood glucose monitor for diabetes self
21 Oct 2010
sanofi-aventis has announced the upcoming launch of the blood
glucose monitoring (BGM) devices BGStar and iBGStar, developed
with its partner AgaMatrix.
BGStar and iBGStar have been designed by listening to the needs and
desires of people with diabetes.
Both products aim to integrate convenient, accurate and easy-to-use blood
glucose management with decision-making support in everyday lives of
people with diabetes. They are planned to be made commercially
available in the first markets in early 2011.
ultra-compact iBGStar (right) can be plugged into an iPhone or iPod touch
and displays results on a full-colour touchscreen. It can also be
used separately for on-the-go testing. The specially-designed and
simple iBGStar Diabetes Manager App will allow data to be easily
managed and communicated to healthcare professionals.
iBGStar and BGStar are based on the patented Dynamic
Electrochemistry technology ensuring accurate and reliable blood
glucose readings, and both devices do not require coding. BGStar has
various feedback features including alerts, programmable reminder
alarms and positive feedback to indicate what the results mean.
A large, backlit display allows results to be quickly and easily
viewed, managed and discussed. In addition, the iBGStar product
range offers users access to a full service telephone hotline and
other support services so people with diabetes can feel more
confident to take charge of their lives.
This is an important step towards sanofi-aventis’ vision of becoming
the leader in global diabetes care by integrating innovative
monitoring technology, therapeutic innovations, personalized
services and support solutions.
“Our patient-centric approach means we truly understand the
challenges faced by people with diabetes,” explained Pierre Chancel,
Senior Vice-President, Global Diabetes Division, sanofi-aventis,
speaking at the 46th Annual European Association for the Study of
Diabetes (EASD) Meeting in Stockholm, Sweden.
“This generation of innovative blood glucose monitors is key to
making diabetes care fit into the everyday lives of people with
diabetes and potentially improving their confidence in managing
their condition. It is an important step toward our goal of
delivering seamless connectivity between diagnostics, treatment and
“Blood glucose values recorded for immediate and future analysis,
forming a complete record, are the basis of well-informed decision
making,” stated Prof Thomas Haak, chief physician at the diabetes
clinic Bad Mergentheim, Germany. “Specifically designed devices,
which fit conveniently into a patient’s daily lifestyle, resulting
in blood glucose self-monitoring at the recommended level, will
improve diabetes management.”
The iBGStar and its diabetes manager app, and the BGStar data
management software are pending CE Mark and FDA 510k review.
managing blood glucose monitoring
For people with diabetes, blood glucose monitoring is essential
for maintaining tight blood glucose control and preventing numerous
diabetes-related complications that can compromise overall health
and quality of life. However, factors such as reliability, accuracy,
discretion and ease-of-use of blood glucose monitors continue to be
issues of concern for a significant proportion of people with